Drug Stocks on Watch as Bipartisian Bill Expected on Capping Price Increases

September 15, 2016 8:31 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Pharmaceutical stocks are on watch Thursday amid reports a bipartisan bill to cap drug price increases will be introduced in both on the House and Senate. The bill is expected to require drug makers to notify the Department of HHS if a price increase of 10% or more is planned.

Related Stocks:

  • Allergan (NYSE: AGN)
  • Mallinckrodt (NYSE: MNK)
  • Mylan (NASDAQ: MYL)
  • Valeant Pharma (NYSE: VRX)
  • Teva (NASDAQ: TEVA)
  • Perrigo (NYSE: PRGO)
  • Shire plc (NASDAQ: SHPG)
  • Endo Int'l (NASDAQ: ENDP)


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Related Entities

Raising Prices

Add Your Comment